Tilray Brands
TLRY · NASDAQ
About TLRY
- Employees
- 2,842
- Headquarters
- Leamington, British Columbia
- Listed
- Jul 19, 2018
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- tilray.com
TLRY key statistics
- Market cap
- 447.80M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 4.23M
- Volume
- 2.90M
- Open price
- $3.03
- High today
- $3.10
- Low today
- $3.01
- 52 Week high
- $16.20
- 52 Week low
- $3.00
Tilray Brands (TLRY) at a glance
Tilray Brands (TLRY) last traded at $3.03, with a market cap of 447.80M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $3.01 and $3.10. The current price is 0.8% above the day's low and 2.3% below its high.
Volume so far is 2.90M shares, below the average of 4.23M shares a day.
Over the past year Tilray Brands has ranged from $3.00 to $16.20, and now sits 0% of the way up that range.
Tilray Brands met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q3 FY26 it reported -$0.32 per share against an estimate of -$0.2054.
The average analyst price target is $8.17, 169.8% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $4.29
- Now
- $3.03
- High
- $17.85
TLRY earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 100.0% on average.
- Q4 FY24: reported -$0.40 per share against an estimate of -$0.2244
- Q1 FY25: reported -$0.40 per share against an estimate of -$0.3672
- Q2 FY25: reported -$1.00 per share against an estimate of -$0.408
- Q3 FY25: reported -$0.96 per share against an estimate of -$0.408
- Q4 FY25: reported -$13.00 per share against an estimate of -$0.238
- Q1 FY26: reported $0.00 per share against an estimate of -$0.2295
- Q2 FY26: reported -$0.43 per share against an estimate of -$0.0136
- Q3 FY26: reported -$0.32 per share against an estimate of -$0.2054
TLRY news
- Sara Montes de Oca
- Press releaseGlobe Newswire
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
- Press releaseGlobe Newswire
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
Tilray Brands Q1 2027 Earnings Call Transcript
- Press releaseGlobe Newswire
Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution
- Rishabh Mishra
Stock Market: Will S&P 500 Open Up or Down Today?
- Press releaseGlobe Newswire
BrewDog’s Winning Streak Rolls on with Gold at the Scottish Beer Awards
- Press releaseGlobe Newswire
BrewDog Rallies Beer Lovers Across the UK to Choose Craft
Similar companies
Companies in the same industry as Tilray Brands
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.